Cryoablation promising for early breast cancer

Cryoablation promising for early breast cancer

(HealthDay)—Cryoablation seems promising for early breast cancer and has minimal risks, according to a study presented at the annual meeting of the American Society of Breast Surgeons, held virtually from April 29 to May 2.

Richard E. Fine, M.D., from the West Cancer Center & Research Institute in Germantown, Tennessee, and colleagues examined the safety and efficacy of cryoablation for women aged 60 years and older with unifocal, ultrasound-visible invasive ductal carcinoma ≤1.5 cm in size; tumors were hormone receptor-positive, human epidermal growth factor receptor 2-negative. One hundred ninety-four patients (mean age, 75 years; mean tumor size, 7.4 mm) met the and received successful treatment per protocol, receiving a freeze-thaw-freeze cycle for 20 to 40 minutes. Patients were followed up at six months and then annually to five years.

The researchers observed no significant device-related adverse events or complications reported among the protocol-treated patients. Most adverse events were minor. Fifteen patients underwent sentinel lymph node biopsies; one had breast cancer-related positive sentinel lymph nodes, with no recurrence at 60 months of follow-up. Overall, 27, one, and 148 patients underwent adjuvant radiation, received chemotherapy, and began endocrine therapy, respectively. During the follow-up visits, more than 95 percent of patients and 98 percent of physicians reported satisfaction from the cosmetic results. Only four of the protocol-treated patients had recurred at a mean of 34.83 months of follow-up (2.06 percent overall recurrence rate).

"Cryoablation potentially represents a dramatic improvement in care for appropriate low-risk , and at three years' posttreatment, the ICE3 trial results are extremely positive," Fine said in a statement.

Explore further

Effect of COVID-19 on breast cancer treatment examined

More information: Press Release
More Information

Copyright © 2021 HealthDay. All rights reserved.

Citation: Cryoablation promising for early breast cancer (2021, May 3) retrieved 30 September 2022 from
This document is subject to copyright. Apart from any fair dealing for the purpose of private study or research, no part may be reproduced without the written permission. The content is provided for information purposes only.

Feedback to editors